Introduction

M
igrants accounted for 37% of the 29 747 new HIV diagnoses reported in the European Union/European Economic Area (EU/EEA) by the European Centre for Disease prevention and Control (ECDC) in 2015; and most of them (13%) were from Sub-Saharan Africa (SSA). 1 The disproportionate burden of HIV infection experienced by migrants in Europe also shapes the Spanish HIV epidemic: 30% (n = 1037) of the 3428 new diagnoses reported in 2015 by the Spanish Surveillance Information System on new HIV diagnosis (SINIVIH) occurred in migrants, 237 (23%) of which were migrant women. 2 Furthermore, in Spain people from Latin America and the Caribbean (LAC) not only account for the majority of the migrant population (37%) 3 but are also the most relevant group among newly diagnosed HIV+ migrants (53%). 2 Late HIV diagnosis is more frequent among migrants than among Spaniards, 2 and this not only has a negative impact on the patient 0 s clinical outcomes but can also lead to increased HIV transmission rates within the community. 4, 5 Several studies have shown how late HIV diagnosis among migrants is related to the presence of barriers to access of health promotion and health care services, including HIV testing, treatment and prevention. 6 Migrants may be differently affected by health care barriers depending on their demographic profile (gender, country of origin, sexual orientation, etc.) 2, 7 and on the socioeconomic vulnerabilities they experience. 8 In Spain, these barriers might be larger for men and for migrants from non-Spanish speaking countries. In a Spanish study, high rates of health care barriers resulting in delayed HIV diagnosis occurred among SSA migrants 7 while among people from LAC health care access challenges were reflected in an increased use of emergency services compared to native Spaniards. 9 Cultural differences, poverty, uncertainty about health entitlements, lack of understanding of the health care system and fear of discrimination can all contribute to health care barriers. 10 These barriers can occur at the patient level (sex, age, education, income, immigration status, personal health practices, etc.), the health care provider level (cultural sensitivity and competence, communication style, bilingualism, etc.) and the health system level (health policy, referrals, opening hours, waiting times, etc.). 10, 11 Gender differences often influence health care access, especially among migrants: male migrants are often seeking care only in case of emergency, 12 while female migrants are more likely to seek care via antenatal and child services. 13 Research examining barriers to health care services among HIVpositive migrants population in Spain is scarce. 6, 11 The current study aims to describe the nature and the prevalence of self-perceived barriers to access health care for migrants living with HIV (MLWH) in Spain, and assess risk factors associated with these barriers, while exploring gender differences.
Methods aMASE
The advancing Migrant Access to health Services in Europe (aMASE) study is a research project conducted within the European Network of Excellence for HIV cohort studies (EuroCoord). aMASE took place in 57 HIV clinics and hospitals across nine EU countries and its methodological design has been previously described.
14 This paper focuses on the Spanish results of the study (aMASE-Spain).
aMASE-Spain
A cross-sectional electronic survey was conducted in 18 HIV clinics and hospitals across 7 Spanish regions, between July 2013 and July 2015. Participating sites are listed in the Annex (Annex 1). The research staff in each site identified and recruited eligible subjects among their HIVpositive patients who fulfilled the following criteria: (1) diagnosed within 5 years of the study date, (2) aged !18 years, (3) foreign-born, (4) resident in Spain for a minimum of 6 months and (5) able to complete, either alone or with assistance, a computer-assisted selfinterview (CASI) in any of the 15 available languages (Amharic, Arabic, Dutch, English, French, German, Greek, Italian, Polish, Portuguese, Russian, Turkish, Tigrinya, Spanish and Somali).
Sample size
An overall effective sample size of 1600 individuals was predetermined at the EU-level for the entire aMASE study. 14 In Spain, 765 participants were recruited, which exceeded the minimum sample size required (N = 100) for the country. Using post-hoc analyses, we were able to determine that this sample size would provide a precision within 3.7% for our main estimate of interest.
Sampling strategy
Interested sites with the ability to recruit at least 40 migrants for the study, and with sufficient financial and human resources to conduct the survey, were invited to participate. A convenience sampling strategy was used to recruit study participants: eligible patients attending participating clinics were approached by research team members and invited to participate in the survey.
Data collection
We used two questionnaires: a self-administrated Patient Questionnaire (PTQ) (with socio-economic, epidemiological, clinical, behavioral, migratory and health services use data); and a Clinical Data Questionnaire (CDQ) completed by clinicians (CD4 count, viral load, HIV virus subtype). Both questionnaires were linked using an anonymous patient study number.
Statistical analysis
The primary outcome variable was defined by the presence of at least one self-reported barrier to health care services ('Barriers in access to health care services'). Explanatory variables included sociodemographic and clinical characteristics such as: age, geographic origin, education, employment, income, HIV transmission route, immigration status (irregular immigrants were defined as: asylum seekers, refugees and undocumented migrants), late diagnosis (CD4 count <350 cells/mm 3 at the time of diagnosis), perceived HIV stigma, perceived race stigma, perceived sexuality stigma, late diagnosis, AIDS at presentation, difficulty accessing food and delayed medical treatment due to medication costs.
Separate analyses were carried out for men and women, since gender was conceptualized as an effect modifier for access to care. 13 We calculated frequencies for categorical variables and median and interquartile range (IQR) for continuous ones. Bivariate associations between exposure variables and the variable of interest were calculated. Risk factors for health care barriers were identified through logistic regression. Variables with a P values lower than 0.10 in bivariate analysis were used to fit multivariable models for both men and women. We constructed the final model through a forward procedure and the best model was selected comparing maximum likelihood values. We calculated odds ratios (ORs) with their 95% confidence intervals (95% CI) for each variable included in the final model. Statistical significance was evaluated using the Wald test and all analyses were performed using STATA software (Version 14.0, College Station, Texas).
Ethical committee clearance
The study received approval from the Ethics Committee of Carlos III Spanish Health Institute and from some of the ethics boards of the hospitals/clinics conducting the study. All participants consented to take part in the study.
Results
Sociodemographic and clinical characteristics
In total, 775 individuals were interviewed. We excluded 93 (12%) individuals who had no information on the primary outcome of interest. We also excluded 10 (1%) transgender individuals because their number was too small to include in a stratified analysis and draw meaningful conclusions. Table 1 summarizes the sociodemographic characteristics of the 672 participants included in the analysis. Among those, 154 (23%) were female and 410 (61%) self-identified as men who have sex with men (MSM). Among women, 50% were from LAC and 31% from SSA, while among men, 66% were from LAC and 11% from Western Europe. Non-regular migrants constituted 15% of the sample; this proportion was higher among women (21%) and people from SSA (33%). Migrants from SSA were more likely to be diagnosed late (65%) and among LAC men, 74% identified themselves as MSM (data not shown).
Self-perceived barriers to health care access
One in five participants reported experiencing at least one barrier to accessing health care in Spain (22%) (table 2). Men (24%) were more likely to report barriers than women (14%).The top three selfperceived barriers to accessing health care were the same in males and females: waiting time for an appointment, lacking a health card and waiting times in clinic. Barriers were more common among migrants from SSA (27%) and in those from other geographical origins (North Africa, North America, Asia and Oceania) (36%), compared to the rest of the participants, notably Spanish speaking migrants. Migrants from these first two groups, mostly experienced barriers related to language, waiting time in the clinic and difficulty finding a general practitioner (GP) (data not shown). Finally, rate of self-perceived barriers to health care was highest among persons who inject drugs (PWID) (38%) compared to heterosexuals (HTX) (18%) and MSM (24%). Migrants who inject drugs were more likely to perceive waiting time for appointment (14%) and uncertainty towards health entitlements (24%) as barriers to health care access (data not shown).
Determinants of barriers to health care access
Univariate analysis determinants of barriers to health care access for men and women are presented in table 3. Among women, health care access barriers were more likely to be perceived in those with university education, an irregular immigration status and medication delay due to treatment cost. Among men, barriers were associated with being from SSA, having a primary or university education, not earning their own wage, having an irregular immigration status, experiencing difficulties accessing food, delaying medical treatment due to medication costs and being stigmatized for their race, sexuality or HIV-positive status. Overall 14% of women and 25% of men who reported barriers to health care were diagnosed late for HIV (CD4 count at diagnosis <350 cells/ mm 3 ). The multivariable logistic analysis (table 4) shows the adjusted risk factors associated with barriers to health care access. For women, these risk factors included: having an irregular immigration status; having a university degree and delaying non-HIV medical treatment due to medication costs. Among men we identified the following risk factors: irregular immigration status, difficulty accessing food and experiencing racial stigma.
Discussion
In this study, we found that approximately one in seven migrant women and one in four migrant men living with HIV in Spain, and already linked to HIV care, reported having previously experienced at least one barrier to access health care. The nature, the prevalence and the risk factors of these barriers are different among men and women and reflect the extreme social and economic vulnerability experienced by a relevant proportion of HIV positive migrants living in Spain.
We found that HIV positive migrant men living in Spain were more likely to report health care barriers compared to women. This finding is in accordance with results from a study conducted in the United Kingdom by Burns et al. 8 The limited engagement of men in health care may reflect their propensity to perceive physicians as emergency care providers rather than continuous care providers, thus only seeking help for complex health issues, 12, 15 On the other hand, women's entry into the health care system is facilitated by their role as caregiver accompanying relatives or through reproductive and child health care services. 16 Despite beneficiating from this 'front door' into the health care system, women often face other types of barriers that hinder their access to care. For instance, a study by Guionnet et al. reported that HIV-positive migrant women living in Spain often perceived their condition as lethal and financially unaffordable 17 even though HIV combination antiretroviral therapy (cART) is free for all people living with HIV residing in Spain, regardless of their legal status. 18 This could either reflect migrant women's limited knowledge of their health care entitlements or them prioritizing their work and providing for their families over attending clinic visits during working hours. 19, 20 Several structural barriers to care were identified in this study. Extended waiting times for appointment and during clinic visits were the most commonly reported barriers for both male and female migrants. Although the sample size for women was small, these results support previous work that has been done in this area 21 and suggest that the rigid schedules of health care centers do not fit migrants' demanding work conditions and timetables. This was corroborated in studies showing that migrants perceive occupational strains linked to job insecurity and inflexible work shifts as a major impediment to their health and are often unable to access care during work hours due to fear of losing their employment. 20, 22 In our study, we also found that migrants from SSA were more likely to experience barriers, especially language barriers, which could eventually exacerbate their social exclusion and lead to their inability to understand the health care system and their health care rights entitlements. 23 On the other hand, migrants from LAC, who are native Spanish speakers, did not report any language barrier.
We identified gender specific determinants of health care barriers. For women, education and financial considerations were specific risk factors for barriers. We found that women with a university degree were more likely to experience barriers to health care and were also less likely to have children, which may cause them to under use antenatal services. 24 Highly educated migrant Ecuadorian women who had to accept jobs for which they are over qualified have been reported to experience poor mental health outcomes, 25 which combined with financial strains and occupational dissatisfaction may exacerbate pre-existing health care barriers. Women who delayed non-HIV treatments due to financial restrictions were also more likely to report health care barriers, thus highlighting a subgroup of women who are particularly vulnerable as they generally earn less income and have a lower rate of employment than men. 26, 27 Men-specific risk factors included difficulty accessing food and racial stigma. Limited food access has been previously associated with low health prioritization and an increased need to focus on food and housing procurement. 28 Furthermore, in those living with HIV, food insecurity is also a risk factor for treatment interruption, morbidity and mortality. 29, 30 As for racial stigma, this is a well-documented risk factor for disparities in health access. 31, 32 In people at risk of or living with HIV, perceived racial stigma has been associated with health care barriers such as: lower trust in health care provider, higher likelihood of missing medical appointments, fear of HIV testing and lower adherence to cART. 33, 34 In both migrant men and women, having an irregular immigration status was the main risk factor for experiencing barriers. In 2012, Spain revoked free and universal access to the health care system for undocumented migrants, with some exceptions such as for conditions of public health relevance which include HIV infections. 35, 36 Although these rights were partly returned in late 2015, irregular migrants are still denied access to the health card. 18 National policies restricting health care access for undocumented migrants have an important negative impact on migrant health as has been widely acknowledged by ECDC and WHO. 22, 37 HIVpositive migrants are particularly vulnerable due to HIV social stigma and the chronic nature of the infection, which requires lifelong treatment and care. 38, 39 Governments should guarantee free access to health care system regardless of migrants' legal status in order to ensure the timely access to treatment, thus resulting in better clinical outcomes for the patient and decreased HIV transmission at community level. 39 Restricting health care access for undocumented migrants not only hampers public health measures but also goes against the fundamental principles of equity in health care access outlined in the international human rights laws which have been ratified by all EU/EEA countries. 39 Facilitating health care access to undocumented immigrants is therefore a human rights obligation.
We would like to acknowledge some study limitations. First, the recruitment of our sample from HIV health facilities has led to an underrepresentation of the most vulnerable patients who still have not accessed the health care system, or are still unaware of their HIV status. It is expected that barriers would be more extreme in this group. Second, there may have been an information bias due to the sensitivity of the information collected (e.g. legal status, sexual orientation, and so on), which we minimized through the migrant-friendly nature of the recruiting centres and by privacy provided by self-reporting to electronic questionnaires. Thirdly, we could not compare the prevalence or effect of barriers between immigrants and native Spaniards, due to the lack of a control group. Finally, due to insufficient sample size, our analysis among women is underpowered, which may lead to imprecision in our estimates within this group. Sample size restriction also made it difficult to assess the risk factors for health care barriers according to specific geographical origins. In spite of this limitation, we have chosen to stratify findings by sex given that findings show clear gender differences that would otherwise become invisible.
Conclusions
The current findings indicate that barriers to health care are common among HIV-positive migrants living in Spain linked to care. Defining and understanding these barriers are therefore key to the development of policies and effective care programs tailored to reach HIV-positive migrants. New health strategies should aim to reduce structural barriers to health care access, especially for vulnerable groups such as undocumented migrants. This is also crucial for achieving UNAIDS 90-90-90 targets with the ultimate goal to control the HIV epidemic by 2020. 40 
